Treatment of Symptomatic Severe Ventricular Secondary Mitral Regurgitation with Impaired Left Ventricular Ejection Fraction (<50%) and No Coronary Artery Disease

Clinical Scenario

This protocol covers patients with severe ventricular secondary mitral regurgitation (SMR) who are symptomatic and have impaired left ventricular ejection fraction (LVEF <50%), without concomitant coronary artery disease. Ventricular SMR is more common than other secondary forms and carries a worse long-term prognosis.

Why Impaired LVEF Changes Management

When LVEF falls below 50% in the setting of symptomatic severe ventricular SMR, specific clinical and echocardiographic criteria determine which interventions are appropriate. The absence of obstructive coronary disease further narrows the differential and focuses the management pathway.

Patients who meet defined criteria and remain symptomatic despite optimised medical therapy represent a distinct population requiring structured, evidence-based escalation.

Treatment Approach (partial overview)

In selected patients with severe ventricular SMR who have progressed to advanced heart failure, the protocol addresses specific surgical or device-based interventions. The complete regimen — including full selection criteria, sequencing, and all clinical decision points — is available below.

Dosages, precise eligibility thresholds, and the full algorithm are not shown here.

Instant Access to Structured Evidence-Based Regimens

References

DOI: 10.1093/eurheartj/ehaf194
  1. Ventricular SMR is more common and associated with worse long-term prognosis.
  2. TEER is recommended to reduce HF hospitalizations and improve quality of life in haemodynamically stable, symptomatic patients with impaired LVEF (<50%) and persistent severe ventricular SMR, despite optimized GDMT and CRT (if indicated), fulfilling specific clinical and echocardiographic criteria.
  3. Heart transplantation or left ventricular assist device (LVAD) implantation should be considered in selected patients with severe ventricular SMR and advanced HF.
View source ↗